140 related articles for article (PubMed ID: 33450239)
1. Stabilization of snail maintains the sorafenib resistance of hepatocellular carcinoma cells.
Zhao H; Cheng X; Yu J; Li Y
Arch Biochem Biophys; 2021 Mar; 699():108754. PubMed ID: 33450239
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitors upregulate Snail via Smad2/3 phosphorylation and stabilization of Snail to promote metastasis of hepatoma cells.
Xu W; Liu H; Liu ZG; Wang HS; Zhang F; Wang H; Zhang J; Chen JJ; Huang HJ; Tan Y; Cao MT; Du J; Zhang QG; Jiang GM
Cancer Lett; 2018 Apr; 420():1-13. PubMed ID: 29410023
[TBL] [Abstract][Full Text] [Related]
3. RMP promotes epithelial-mesenchymal transition through NF-κB/CSN2/Snail pathway in hepatocellular carcinoma.
Zhou W; Wang Q; Xu Y; Jiang J; Guo J; Yu H; Wei W
Oncotarget; 2017 Jun; 8(25):40373-40388. PubMed ID: 28423737
[TBL] [Abstract][Full Text] [Related]
4. Activation of phosphatidylinositol 3-kinase/AKT/snail signaling pathway contributes to epithelial-mesenchymal transition-induced multi-drug resistance to sorafenib in hepatocellular carcinoma cells.
Dong J; Zhai B; Sun W; Hu F; Cheng H; Xu J
PLoS One; 2017; 12(9):e0185088. PubMed ID: 28934275
[TBL] [Abstract][Full Text] [Related]
5. Post-transcription mediated Snail stabilization is involved in radiation exposure induced invasion and migration of hepatocarcinoma cells.
Dong L; Zhang X; Xiang W; Ni J; Zhou W; Li H
Biomed Pharmacother; 2018 Jul; 103():767-772. PubMed ID: 29684855
[TBL] [Abstract][Full Text] [Related]
6. Regorafenib reverses HGF-induced sorafenib resistance by inhibiting epithelial-mesenchymal transition in hepatocellular carcinoma.
Chen W; Yang J; Zhang Y; Cai H; Chen X; Sun D
FEBS Open Bio; 2019 Feb; 9(2):335-347. PubMed ID: 30761258
[TBL] [Abstract][Full Text] [Related]
7. Valproic acid (VPA) promotes the epithelial mesenchymal transition of hepatocarcinoma cells via transcriptional and post-transcriptional up regulation of Snail.
Wu L; Feng H; Hu J; Tian X; Zhang C
Biomed Pharmacother; 2016 Dec; 84():1029-1035. PubMed ID: 27768928
[TBL] [Abstract][Full Text] [Related]
8. Long non‑coding RNA H19 is involved in sorafenib resistance in hepatocellular carcinoma by upregulating miR‑675.
Xu Y; Liu Y; Li Z; Li H; Li X; Yan L; Mao J; Shen J; Chen W; Xue F
Oncol Rep; 2020 Jul; 44(1):165-173. PubMed ID: 32627034
[TBL] [Abstract][Full Text] [Related]
9. Identification of biomarkers associated with partial epithelial to mesenchymal transition in the secretome of slug over-expressing hepatocellular carcinoma cells.
Karaosmanoğlu O; Banerjee S; Sivas H
Cell Oncol (Dordr); 2018 Aug; 41(4):439-453. PubMed ID: 29858962
[TBL] [Abstract][Full Text] [Related]
10. The anti-tumor activities of Neferine on cell invasion and oxaliplatin sensitivity regulated by EMT via Snail signaling in hepatocellular carcinoma.
Deng G; Zeng S; Ma J; Zhang Y; Qu Y; Han Y; Yin L; Cai C; Guo C; Shen H
Sci Rep; 2017 Jan; 7():41616. PubMed ID: 28134289
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
Xia H; Ooi LL; Hui KM
Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579
[TBL] [Abstract][Full Text] [Related]
12. Treatment with a new benzimidazole derivative bearing a pyrrolidine side chain overcomes sorafenib resistance in hepatocellular carcinoma.
Suk FM; Liu CL; Hsu MH; Chuang YT; Wang JP; Liao YJ
Sci Rep; 2019 Nov; 9(1):17259. PubMed ID: 31754201
[TBL] [Abstract][Full Text] [Related]
13. Implications of Withaferin A for the metastatic potential and drug resistance in hepatocellular carcinoma cells via Nrf2-mediated EMT and ferroptosis.
Zhang Y; Tan Y; Liu S; Yin H; Duan J; Fan L; Zhao X; Jiang B
Toxicol Mech Methods; 2023 Jan; 33(1):47-55. PubMed ID: 35592903
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
[TBL] [Abstract][Full Text] [Related]
15. Activation of phosphatidylinositol 3-kinase/Akt signaling mediates sorafenib-induced invasion and metastasis in hepatocellular carcinoma.
Wang H; Xu L; Zhu X; Wang P; Chi H; Meng Z
Oncol Rep; 2014 Oct; 32(4):1465-72. PubMed ID: 25070581
[TBL] [Abstract][Full Text] [Related]
16. Epithelial-to-Mesenchymal Transition: A Mediator of Sorafenib Resistance in Advanced Hepatocellular Carcinoma.
Mir N; Jayachandran A; Dhungel B; Shrestha R; Steel JC
Curr Cancer Drug Targets; 2017; 17(8):698-706. PubMed ID: 28460616
[TBL] [Abstract][Full Text] [Related]
17. Serum response factor induces epithelial to mesenchymal transition with resistance to sorafenib in hepatocellular carcinoma.
Bae JS; Noh SJ; Kim KM; Jang KY; Chung MJ; Kim DG; Moon WS
Int J Oncol; 2014 Jan; 44(1):129-36. PubMed ID: 24173109
[TBL] [Abstract][Full Text] [Related]
18. Integrated analysis of multiple receptor tyrosine kinases identifies Axl as a therapeutic target and mediator of resistance to sorafenib in hepatocellular carcinoma.
Pinato DJ; Brown MW; Trousil S; Aboagye EO; Beaumont J; Zhang H; Coley HM; Mauri FA; Sharma R
Br J Cancer; 2019 Mar; 120(5):512-521. PubMed ID: 30765873
[TBL] [Abstract][Full Text] [Related]
19. AP-2β inhibits hepatocellular carcinoma invasion and metastasis through Slug and Snail to suppress epithelial-mesenchymal transition.
Yang L; Qiu J; Xiao Y; Hu X; Liu Q; Chen L; Huang W; Li X; Li L; Zhang J; Ding X; Xiang S
Theranostics; 2018; 8(13):3707-3721. PubMed ID: 30026878
[TBL] [Abstract][Full Text] [Related]
20. αB-crystallin complexes with 14-3-3ζ to induce epithelial-mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma.
Huang XY; Ke AW; Shi GM; Zhang X; Zhang C; Shi YH; Wang XY; Ding ZB; Xiao YS; Yan J; Qiu SJ; Fan J; Zhou J
Hepatology; 2013 Jun; 57(6):2235-47. PubMed ID: 23316005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
